We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+10.92%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$13.7B
AUM Growth
+$3.66B
Cap. Flow
+$2.6B
Cap. Flow %
18.96%
Top 10 Hldgs %
51.2%
Holding
3,395
New
1,045
Increased
548
Reduced
607
Closed
1,119

Sector Composition

Rank Sector Weight
1 Technology 8.67%
2 Consumer Discretionary 5.65%
3 Financials 5.29%
4 Healthcare 4.91%
5 Materials 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLGL icon
2076
Sol-Gel Technologies
SLGL
$288M
$11K ﹤0.01%
+1,047
New +$14K
LPTV
2077
DELISTED
Loop Media, Inc.
LPTV
$11K ﹤0.01%
+11,871
New +$6.99K
SCRMW
2078
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$11K ﹤0.01%
25,005
CONXW
2079
DELISTED
CONX Corp. Warrant
CONXW
$11K ﹤0.01%
37,500
NGM
2080
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$11K ﹤0.01%
+12,821
New +$11.3K
DMK
2081
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$11K ﹤0.01%
+16,558
New +$9.61K
ALUR.WS
2082
DELISTED
Allurion Technologies Warrants
ALUR.WS
$10K ﹤0.01%
23,666
+61
+0.3% +$40
BAERW icon
2083
Bridger Aerospace Warrant
BAERW
$8.48M
$10K ﹤0.01%
49,968
NRSN icon
2084
NeuroSense Therapeutics
NRSN
$18M
$10K ﹤0.01%
+13,998
New +$9.3K
RNAC icon
2085
Cartesian Therapeutics
RNAC
$268M
$10K ﹤0.01%
+502
New +$15K
SOPA
2086
DELISTED
Society Pass
SOPA
$10K ﹤0.01%
+2,319
New +$10.3K
ACB
2087
Aurora Cannabis
ACB
$185M
$9K ﹤0.01%
+2,043
New +$9.85K
HELP
2088
Cybin Inc
HELP
$720M
$9K ﹤0.01%
+633
New +$11.8K
CYN icon
2089
Cyngn
CYN
$17.7M
$9K ﹤0.01%
+4
New +$16.3K
GRI
2090
GRI Bio
GRI
$2.6M
$9K ﹤0.01%
+1
New +$41.7K
POET icon
2091
POET Technologies
POET
$1.54B
$9K ﹤0.01%
+10,235
New +$17.9K
ASST icon
2092
Strive Inc
ASST
$1.05B
$8K ﹤0.01%
125
-203
-62% -$9.47K
FRMM
2093
Forum Markets
FRMM
$79.5M
$8K ﹤0.01%
197
+144
+272% +$10.1K
CATX icon
2094
Perspective Therapeutics
CATX
$342M
$8K ﹤0.01%
2,027
-8,244
-80% -$23.2K
GDHG icon
2095
Golden Heaven Group Holdings
GDHG
$78.5M
$8K ﹤0.01%
+1
New +$231K
GTBP icon
2096
GT Biopharma
GTBP
$11.5M
$8K ﹤0.01%
+1,126
New +$8.23K
LZM.WS icon
2097
Lifezone Metals Ltd Warrants
LZM.WS
$29.5M
$8K ﹤0.01%
15,000
TMCWW
2098
TMC The Metals Company Warrants
TMCWW
$1.19M
$8K ﹤0.01%
68,687
-311
-0.5% -$35
SUNE
2099
SUNation Energy
SUNE
$10.8M
0
TVRD
2100
Tvardi Therapeutics
TVRD
$23.4M
$8K ﹤0.01%
+304
New +$12.6K

Similar funds

HRT Financial's Q4 2023 Portfolio in Review

As of Q4 2023, HRT Financial held 3,395 positions worth $13.7B, up 37% from $10B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

HRT Financial deployed $2.6B of net new capital in Q4 2023, opening 1,045 new positions and adding to 548 existing holdings. Its largest new stake was Linde: 727,095 shares worth $299M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Broadcom, an estimated $83.7M trimmed.

  • HRT Financial's largest Q4 2023 buy was Linde: 727,095 shares worth $299M.
  • HRT Financial added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.94B increase.
  • HRT Financial's biggest Q4 2023 reduction was Broadcom, cutting an estimated $83.7M.
  • HRT Financial fully exited Newmont in Q4 2023, selling an estimated $140M.
  • HRT Financial's ten largest holdings make up 51% of its $13.7B portfolio in Q4 2023.
  • HRT Financial opened 1,045 new positions and closed 1,119 in Q4 2023.
  • HRT Financial's portfolio value rose 37% quarter-over-quarter to $13.7B.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.